Number | Sex | Age (years) | Histology | Tumor site | Follow-up | Death of disease | CRP (mg/dl) | Confounding diagnosis | |
---|---|---|---|---|---|---|---|---|---|
Tumor | CVD | ||||||||
1 | Male | 68 | Conventional | Prox S3 | 2.7 | No | 0.81 | Hypertensive heart insufficiency II, Hyperlipidemia | |
2 | Male | 85 | Conventional | Distal S3 | 11.1 | No | 0.10 | Hypertension | |
3 | Male | 52 | Conventional | Distal S3 | 6.3 | No | 0.22 | Hypertension | |
4 | Male | 79 | Conventional | Distal S3 | 3.7 | No | 0.85 | Hypertension, type II diabetes, obesity | |
5 | Male | 81 | Conventional | Distal S3 | 2.8 | No | 1.18 | Prostataca | |
6 | Female | 81 | Conventional | Distal S3 | 6.0 | No | 2.24 | ||
7 | Female | 79 | Conventional | Distal S3 | 1.4 | Yes | 0.87 | ||
8 | Male | 71 | Conventional | Prox S3 | 8.9 | No | 0.40 | ||
9 | Male | 82 | Conventional | Distal S3 | 1.6 | Yes | 0.00 | ||
10 | Male | 58 | Chondroid | Distal S3 | 4.2 | No | 0.40 | Hypertension, hyperlipidemia | |
11 | Male | 84 | Conventional | Distal S3 | 4.1 | Yes | 1.10 | ||
12 | Male | 56 | Chondroid | Prox S3 | 8.1 | No | 0.15 | Hypertension, obesity | |
13 | Male | 73 | Conventional | Prox S3 | 2.1 | No | 0.70 | ||
14 | Male | 35 | Conventional | Distal S3 | 1.6 | Yes | 0.90 | ||
15 | Female | 66 | Conventional | Prox S3 | 3.6 | No | 0.58 | ||
16 | Male | 62 | Conventional | Prox S3 | 4.3 | No | 3.30 | ||
17 | Male | 62 | Conventional | Prox S3 | 3.0 | Yes | 3.10 | ||
18 | Male | 20 | Conventional | Distal S3 | 0.5 | Yes | 0.81 | ||
19 | Female | 77 | Conventional | Prox S3 | 16.5 | No | 1.32 | Basalioma | |
20 | Female | 77 | Chondroid | Prox S3 | 3.0 | Yes | 0.14 | ||
21 | Male | 60 | Conventional | Distal S3 | 18.8 | No | 1.95 | Hypertension | |
22 | Female | 68 | Dedifferentiated | Prox S3 | 4.4 | Yes | 0.20 | ||
23 | Male | 52 | Conventional | Distal S3 | 2.1 | No | 7.60 | Hypertension, renal insufficiency, chon. Prostatitis | |
24 | Male | 77 | Conventional | Distal S3 | 1.3 | Yes | 8 |